Parra-Giraldo, C. M.

P270

J. Fungi 2023, 9, 430.

The mortality attributable to candidemia in C. auris is higher than that in other Candida species: Myth or reality?

Alvarez-Moreno, CA. Morales-López, S. Rodriguez, G. J. Rodriguez, J. Y. Robert, E. Picot, C. Ceballos-Garzon, A. Parra-Giraldo, C. M. Le Pape, P.

https://doi.org/10.3390/jof9040430

P249

PLoS One 2022.

CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata.

Ceballos-Garzon, A. Roman, E. Pla, J. Pagniez, F. Amado, D. Alméciga-Díaz, C. J. Le Pape, P. Parra-Giraldo, C. M.

https://doi.org/10.1371/journal.pone.0265777

P247

Int. J. Antimicrob. Agents. 2022.

Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing.

Ceballos-Garzon, A. Garcia-Effron, G. Cordoba, S. Rodriguez, J. Y. Alvarez-Moreno, C. Le Pape, P. Parra-Giraldo, C. M. Morales-López, S.

https://doi.org/10.1016/j.ijantimicag.2022.106558

P245

J. Antimicrob. Chemother. 2022, 77, 585–597.

Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.

Ceballos-Garzon, A. Monteoliva, L. Gil, C. Alvarez-Moreno, C. Vega-Vela, N. E. Engelthaler, D. M. Bowers, J. Le Pape, P. Parra-Giraldo, C. M.

https://doi.org/10.1093/jac/dkab454

P210

J. Antimicrob. Chemother. 2020, 75, 1187-1193.

Impact of Calmodulin Inhibition by Fluphenazine on Susceptibility, Biofilm Formation and Pathogenicity of Caspofungin-Resistant Candida glabrata.

Ceballos-Garzon, A. Amado, D. Robert, E. Parra-Giraldo, C. M. Le Pape, P.

doi: 10.1093/jac/dkz565